Illuminating a Hidden Risk: The Genetic Contribution to Acute Myocarditis.

Autor:	Ammirati E; De Gasperis Cardio Center, Transplant Center, Niguarda Hospital, Milano, Italy; Department of Health Sciences, University of Milano-Bicocca, Monza, Italy., Kontorovich AR; Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Cooper LT Jr; Mayo Clinic, Jacksonville, Florida, USA. Electronic address: cooper.leslie@mayo.edu.
Jazyk:	angličtina
Zdroj:	JACC. Heart failure [JACC Heart Fail] 2024 Jun; Vol. 12 (6), pp. 1112-1114.
DOI:	10.1016/j.jchf.2024.03.015
Abstrakt:	Competing Interests: Funding Support and Author Disclosures Dr Ammirati has received grants from the Italian Ministry of Health (GR-2019-12368506; principal investigator of the investigator-driven MYTHS [Myocarditis Therapy with Steroids] trial) and the NextGenerationEU (PNRR-MAD-2022-12376225); and has received consulting fees from Kiniksa, Cytokinetics, and AstraZeneca. Dr Kontorovich has received research funding from Akcea Pharmaceuticals; and has received speaker fees from Ambry Genetics. Dr Cooper has received consulting fees from BMS, CardiolRx, and Moderna; and is an equity owner in Stromal Therapeutics.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu